Medtech partnership

My+Care enters medtech partnership
My+Care™ > Partnership  > Medtech partnership

Medtech partnership

PRESS RELEASE

 

Kista, Sweden, 30 January 2018

 

NOTE has entered an agreement with CellMark AB for the manufacture of a new medtech product. Estimated sales value of some SEK 25 million in 2018. The scheduled production start is in the first quarter. The product, My+Care™, is a wristband that uses AI (artificial intelligence) to analyse and monitor user health. By capturing data, risks can be predicted, relatives and carers informed, thus preventing many injuries and accidents.

“Our medtech initiative remains successful. This is a great example of a complete solution, where, by bringing competence early in the process, we can support the customer so their product comes to market faster,” commented Per Ovrén, NOTE’s CEO and President.

 

“CellMark views NOTE as a long-term partner for developing and manufacturing medtech products, taking complete responsibility for testing, sourcing and manufacturing life-saving solutions, which fits CellMark’s business model as a global platform for medtech entrepreneurs,” responded Niclas Möttus-Olsson, President of CellMark Medical.

For more information, please contact:


Per Ovrén, CEO and President of NOTE, tel. +46 (0)73 440 7727

Henrik Nygren, CFO of NOTE, tel. +46 (0)70 977 0686
Niclas Möttus-Olsson, President of CellMark Medical, tel. +46 (0)72 025 5563

 

About NOTE:
NOTE is one of the leading Northern European manufacturing and logistics partners for production of electronics-based products. NOTE produces PCBAs, subassemblies and box build products. NOTE’s offering covers the complete product lifecycle, from design to after-sales. NOTE has a presence in Sweden, Finland, the UK, Estonia and China. Sales over the past 12 months were SEK 1,139 million; the group has approximately 900 employees. NOTE is listed on Nasdaq Stockholm. For more information, please go to www.note.eu.

 

About CellMark:
CellMark is a leader in international trade and business development across global industries. The company delivers services within sales & marketing, finance, logistics and business development. Through a network of 70 offices in 30-plus countries, CellMark brings entrepreneurs from a broad spectrum of sectors together. CellMark has 700 employees, yearly sales of USD 3 billion and a trading volume of some 6.5 million tons. For more information, please go to www.cellmark.com.

 

This information was submitted for publication at 8:30 a.m. CET on 30 January 2018.
https://www.note.eu/en/investor-relations/press-releases/press/?id=AB2AE2B6F715625B …